This notice is for prior information only
Legal Basis:
Regulation (EU, Euratom) No 2018/1046
Section I: Contracting authority
I.1)Name and addressesOfficial name: European Health and Digital Executive Agency (HaDEA), HADEA.A - Health and Food
Postal address: COV2, Place Charles Rogier 16
Town: Brussels
NUTS code:
BE100 Arr. de Bruxelles-Capitale / Arr. Brussel-HoofdstadPostal code: B-1210
Country: Belgium
E-mail:
hadea-eu4h-tenders@ec.europa.euInternet address(es): Main address:
https://hadea.ec.europa.eu I.3)CommunicationAdditional information can be obtained from the abovementioned address
I.4)Type of the contracting authorityEuropean institution/agency or international organisation
I.5)Main activityGeneral public services
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Feasibility Study, Design and Prototype Development for a Mapping Platform on COVID-19 Therapeutics in the EU
Reference number: HADEA/2021/OP/0009-PIN
II.1.2)Main CPV code73000000 Research and development services and related consultancy services
II.1.3)Type of contractServices
II.1.4)Short description:
Service contract encompassing the feasibility assessment, the design and prototype development of an interactive platform mapping the production capacity and supply of COVID-19 therapeutics in the EU including products in research and development phases. Such therapeutics can include ICU medicines, heparin, dexamethasone and antibiotics, in vitro diagnostics devices/companion diagnostics.
II.1.5)Estimated total valueValue excluding VAT: 5 000 000.00 EUR
II.1.6)Information about lotsThis contract is divided into lots: no
II.2)Description
II.2.2)Additional CPV code(s)73000000 Research and development services and related consultancy services
II.2.3)Place of performanceNUTS code: BE100 Arr. de Bruxelles-Capitale / Arr. Brussel-Hoofdstad
Main site or place of performance:
COV2, Place Charles Rogier 16, B-1210 Brussels, BELGIUM.
II.2.4)Description of the procurement:
Feasibility study, design and prototype development for a mapping platform on COVID-19 therapeutics in the EU.
II.2.14)Additional information
Please consult the procurement documents available at the address indicated in section I.3).
II.3)Estimated date of publication of contract notice:27/08/2021
Section IV: Procedure
IV.1)Description
IV.1.8)Information about the Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: no
Section VI: Complementary information
VI.3)Additional information:
Please consult the procurement documents available at the address indicated in section I.3).
VI.5)Date of dispatch of this notice:06/08/2021